The chemical composition of some marketed AMPs. For gramicidin D and teicoplanin, only the most ample elements on the clinically used mixtures are shown. Any prospective conflicts of interest, including funding from pharmaceutical corporations or own investments in relevant industries, are completely disclosed from the research publications. This disclosure is https://robertl840tmh1.tokka-blog.com/profile